VentriPoint Diagnostics Statistics
Want to see TSE:VPT full AI Analyst Report?
VentriPoint Diagnostics (VPT) Stock Statistics & Valuation Metrics
Total Valuation
VentriPoint Diagnostics has a market cap or net worth of CAD 12.54M. The enterprise value is CAD 22.72M.
- Market Cap
- CAD 12.54M
- Enterprise Value
- CAD 22.72M
Share Statistics
VentriPoint Diagnostics has 192,877,940 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 192,877,940
- Owned by Insiders
- 1.88%
- Owned by Institutions
- ―
Financial Efficiency
VentriPoint Diagnostics’s return on equity (ROE) is 0.78 and return on invested capital (ROIC) is 222.24%.
- Return on Equity (ROE)
- 0.78
- Return on Assets (ROA)
- -6.78
- Return on Invested Capital (ROIC)
- 222.24%
- Return on Capital Employed (ROCE)
- 0.85
- Revenue Per Employee
- 17.99K
- Profits Per Employee
- -320.02K
- Employee Count
- 10
- Asset Turnover
- 0.38
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of VentriPoint Diagnostics is -4.98. VentriPoint Diagnostics’s PEG ratio is -0.06.
- PE Ratio
- -4.98
- PS Ratio
- 84.84
- PB Ratio
- -3.17
- Price to FCF
- -6.52
- Price to Operating Cash Flow
- -6.31
- PEG Ratio
- -0.06
Income Statement
In the last 12 months, VentriPoint Diagnostics had revenue of 179.93K and earned -3.20M in profits. Earnings per share was -0.02.
- Revenue
- 179.93K
- Gross Profit
- 118.69K
- Operating Income
- -3.40M
- Pretax Income
- -3.25M
- Net Income
- -3.20M
- EBITDA
- -2.67M
- Earnings Per Share (EPS)
- -0.02
Cash Flow
In the last 12 months, operating cash flow was -1.92M and capital expenditures -5, giving a free cash flow of -1.92M billion.
- Operating Cash Flow
- -1.92M
- Free Cash Flow
- -1.92M
- Free Cash Flow per Share
- -0.01
Dividends & Yields
VentriPoint Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -15.35%
- Earnings Yield
- -19.09%
Stock Price Statistics
- Beta
- -0.78
- 52-Week Price Change
- -35.00%
- 50-Day Moving Average
- 0.08
- 200-Day Moving Average
- 0.11
- Relative Strength Index (RSI)
- 39.39
- Average Volume (3m)
- 119.45K
Important Dates
VentriPoint Diagnostics upcoming earnings date is Dec 02, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Sep 01, 2026
- Next Earnings Date
- Dec 02, 2026
- Ex-Dividend Date
- ―
Financial Position
VentriPoint Diagnostics as a current ratio of 0.08, with Debt / Equity ratio of -63.20%
- Current Ratio
- 0.08
- Quick Ratio
- 0.08
- Debt to Market Cap
- 0.11
- Net Debt to EBITDA
- -0.96
- Interest Coverage Ratio
- -6.44
Taxes
In the past 12 months, VentriPoint Diagnostics has paid -52.20K in taxes.
- Income Tax
- -52.20K
- Effective Tax Rate
- 0.02
Enterprise Valuation
VentriPoint Diagnostics EV to EBITDA ratio is -8.90, with an EV/FCF ratio of -7.70.
- EV to Sales
- 100.28
- EV to EBITDA
- -8.90
- EV to Free Cash Flow
- -7.70
- EV to Operating Cash Flow
- -7.70
Balance Sheet
VentriPoint Diagnostics has CAD 333.63K in cash and marketable securities with CAD 2.62M in debt, giving a net cash position of -CAD 2.28M billion.
- Cash & Marketable Securities
- CAD 333.63K
- Total Debt
- CAD 2.62M
- Net Cash
- -CAD 2.28M
- Net Cash Per Share
- -CAD 0.01
- Tangible Book Value Per Share
- -CAD 0.02
Margins
Gross margin is 89.55%, with operating margin of -1624.48%, and net profit margin of -1568.50%.
- Gross Margin
- 89.55%
- Operating Margin
- -1624.48%
- Pretax Margin
- -1603.83%
- Net Profit Margin
- -1568.50%
- EBITDA Margin
- -1126.67%
- EBIT Margin
- -1168.12%
Analyst Forecast
The average price target for VentriPoint Diagnostics is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 89.06%
- EPS Growth Forecast
- 37.62%
Scores
- Smart Score
- ―
- AI Score
- 46

